The percentage of endoscopic resolution of Barrett’s esophagus at 3 months is non-inferior with two simple protocol versus the standard protocol.
ID
Bron
Aandoening
Barrett's esophagus, Barrett's neoplasia, Barrett's dysplasia, Radiofrequency ablation, Intestinal metaplasia
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary outcome:<br>
Percentage of endoscopically visual surface regression of BE epithelium at 3 months, as scored
by two independent endoscopists blinded to the treatment regimen.
Achtergrond van het onderzoek
In this trial, three regimens for circumferential
radiofrequency ablation treatment with the RFA self-sizing
balloonWill be compared The first regimen is the standardly
used regimen (1x-clean-1x) The two simple regimens are
the simplified protocol with 2x-ablation-no clean and the
simplified protocol with 1x ablation-no clean.
Doel van het onderzoek
The percentage of endoscopic resolution of Barrett’s esophagus at 3 months is non-inferior with two simple protocol versus the standard protocol.
Onderzoeksopzet
1. At follow-up endscopy at 3 months after the circumferential RFA treatment the primary endpoint will be scored
2. During and in the interval from directly after the circumferential RFA procedure until follow-up endoscopy after 3 months, the secondary endpoints are scored
Onderzoeksproduct en/of interventie
Circumferential radiofrequency ablation of Barrett's
esophagus with the Self-sizing RFA balloon.
Inspection of the Barrett’s segment and randomization
The esophagus is evaluated using white light high-resolution
endoscopy (WLE) and narrow band imaging (NBI). The
extent of columnar lined esophagus is documented according
to the Prague C&M classification15 and by taking still images
with WLE+NBI at 1 cm intervals. In the absence of visible
abnormalities and no severe stenosis, patients are
subsequently randomized to circumferential ablation with the
Self Sizing RFA balloon using the simplified or the standard
ablation regiment.
Patients will be blinded for the administered treatment
regimen.
Standard ablation regimen
After mapping and randomization, the Barrett’s segment is
flushed with the mucolytic agent acetylcysteine (1%)
followed by flushing with tap water. The Self Sizing RFA
balloon (GI Solutions Covidien, Sunnyvale, CA) is then
introduced and positioned at the desired treatment zone. The
device is inflated, and the electrode unfurls until the
electrode contacts the esophageal wall. Under visual control
the BE is ablated (12 J/cm2 at 300 Watt) working proximal
to distal using visual repositioning. A small overlap (i.e.
<1cm) between ablation zones is allowed. After the first
ablation pass, the endoscope is removed followed by removal
of the ablation catheter. The coagulum is cleaned off the
balloon catheter. The endoscope is reintroduced to irrigate
and suction the ablation zone. A distal attachment cap may
be attached to the tip of the endoscope to gently wipe of the
coagulum from the ablated segment. After irrigating and
suctioning the debris away as much as possible, the Self
Sizing RFA RCT November 2014 vs 1 Page 10 van 16
ablation zone is cleaned by forcefully flushing water through
a spraying catheter. The stomach is emptied and deflated,
the endoscope is removed and the ablation catheter is
reintroduced to repeat the ablation. After this second
ablation no additional cleaning of the ablation zone is
required. First, the endoscope is removed, followed by
careful removal of the ablation catheter.
Simplified ablation regimens:
In the first simplified ablation regimen flushing with the
mucolytic agent acetylcysteine (1%) is not performed, but
the esophageal wall will cleaned with water through the
waterjet channel of the endoscope. After the first ablation
(12 J/cm2 at 300W), immediately a second ablation is
performed of the same zone without a cleaning step. After
deflation, the balloon is advanced distally to ablate
subsequent zones with a double ablation in an identical way.
In the second simplified ablation regimen flushing with the
mucolytic agent acetylcysteine (1%) is not performed, but
the esophageal wall will cleaned with water through the
waterjet channel of the endoscope. There is only one
ablation instead of two.
Publiek
J.J.G.H.M. Bergman
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
0031 (0)205663556
j.j.bergman@amc.uva.nl
Wetenschappelijk
J.J.G.H.M. Bergman
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
0031 (0)205663556
j.j.bergman@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Patients aged 18-85 years, with biopsy proven LGD, HGD or EC in a BE after local expert
pathology review.
2. Scheduled circumferential ablation for BE with flat LGD, HGD, or for BE after prior endoscopic
resection (ER) for lesions containing HGD or EC (<2 cm and <50% of the circumference).
3. Pretreatment biopsies and/or ER specimens reviewed by a local expert pathologist.
4. Written informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Patients with a BE segment < 2cm or >15 cm prior to ER.
2. Any prior endoscopic ablation treatment.
3. Significant esophageal stenosis prior to initial treatment, preventing passage of a therapeutic
endoscope OR any prior endoscopic dilatation for esophageal stenosis.
4. Presence of esophageal varices.
5. Anti-coagulant therapy (apart from aspirin or NSAID) that cannot be discontinued prior to ER
or RFA, OR uncorrectable hemostatic disorders.
6. In case of prior ER: patients with ER of multiple lesions in a single ER session are not eligible, if
one of the resections measures more than the aforementioned size criteria, OR if resections
of different lesions are not separated by a free circumferential segment of at least 1 cm.
7. In case of prior ER: a specimen showing carcinoma with positive vertical resection margins,
deep submucosal invasion (>T1sm1), poorly or undifferentiated cancer (G3 or G4), or
lymphatic/vascular invasion.
8. In case of prior ER: invasive cancer in any of the biopsies obtained at high-resolution
endoscopy after ER.
9. An interval > 6 months between the last high-resolution endoscopy with biopsies and RFA.
10. An interval < 6 weeks between ER and RFA.
11. Patients unable to give informed consent.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5059 |
NTR-old | NTR5191 |
Ander register | NL51663.018.14 CCMO : 2014_380 METC AMC |